Parallel is a leading multi-state operator focused on pioneering well-being and improving quality of life through cannabinoids. With a strong and expanding presence in high-growth markets across the U.S., Parallel’s commitment to innovation is driving the industry to better consumer and patient lives.
One of the largest privately-held, vertically-integrated multi-state cannabis operators in the U.S.
High quality assets and leading position in high-growth markets
Blue-chip management team with track record of building global brands
Proven track record of strategic M&A and partnerships
Organizational emphasis on R&D and innovation
On February 22, 2021, Parallel announced that it expects to become a publicly traded company on the Canadian NEO exchange through a business combination with Ceres Acquisition Corp., a special purpose acquisition corporation (SPAC).